Systemic Synuclein Sampling Study (S4)

Completed

Conditions studied: Parkinson's Disease

In brief

The purpose of this study is to measure alpha-synuclein in peripheral body tissues and fluids in Parkinson's disease (PD). This may help in developing better treatments for PD patients in the future.

Key facts

Study ID

NCT02572713

Run by

Michael J. Fox Foundation for Parkinson's Research

People needed

80

Starts

2015-10-01

Expected to finish

2017-08-01

Last updated by the study team

2017-08-17

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

• University of Alabama at Birmingham — Birmingham, Alabama, United States
• Mayo Clinic Arizona — Scottsdale, Arizona, United States
• Institute for Neurodegenerative Disorders — New Haven, Connecticut, United States
• Oregon Health & Science University — Portland, Oregon, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• Toronto Western Hospital Movement Disorders Centre — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.